financetom
Business
financetom
/
Business
/
Ormat Technologies Q1 Adjusted Earnings, Revenue Rise; Reaffirms Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ormat Technologies Q1 Adjusted Earnings, Revenue Rise; Reaffirms Guidance
May 8, 2024 3:34 PM

06:02 PM EDT, 05/08/2024 (MT Newswires) -- Ormat Technologies ( ORA ) reported Q1 adjusted earnings late Wednesday of $0.65 per diluted share, up from $0.51 a year ago.

Analysts polled by Capital IQ expected $0.61.

Revenue for the quarter ended March 31 rose to $224.2 million from $185.2 million a year ago. Analysts expected $218.8 million.

For 2024, the company said it continues to expect revenue of $860 million to $910 million. The consensus is for $889.5 million.

Ormat ( ORA ) kept its quarterly dividend at $0.12 per share, payable June 5 to stockholders of record May 22.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Woodward Names Karrie Bem as Chief Compliance Officer
Woodward Names Karrie Bem as Chief Compliance Officer
Aug 29, 2024
05:30 PM EDT, 08/29/2024 (MT Newswires) -- Woodward (WWD) said Thursday it has appointed Karrie Bem as chief compliance officer, starting Sept. 16. Bem was most recently general counsel of national security for space at Lockheed Martin's ( LMT ) Lockheed Martin Space business division, the company said. ...
What's Going On With Brenmiller Energy Stock After Earnings?
What's Going On With Brenmiller Energy Stock After Earnings?
Aug 29, 2024
Brenmiller Energy Ltd ( BNRG ) shares are soaring after the company reported its first-half financial results after Thursday's closing bell. Here's a look at the details. The Details: Brenmiller Energy ( BNRG ) reported first-half losses per share of 45 cents, up from losses of $3.02 per share year-over-year. The company announced it is exploring ways to expand its...
Artiva Biotherapeutics Reports Wider Q2 Loss, No Revenue
Artiva Biotherapeutics Reports Wider Q2 Loss, No Revenue
Aug 29, 2024
05:31 PM EDT, 08/29/2024 (MT Newswires) -- Artiva Biotherapeutics ( ARTV ) reported a Q2 loss late Thursday of $22 per diluted share, wider than a loss of $14.09 a year earlier. Four analysts surveyed by Capital IQ expected a loss of $4.40. No revenue for the quarter ended June 30 was reported. Revenue a year earlier was $3.5 million....
P3 Health Partners Appoints Leif Pedersen as CFO
P3 Health Partners Appoints Leif Pedersen as CFO
Aug 29, 2024
05:30 PM EDT, 08/29/2024 (MT Newswires) -- P3 Health Partners ( PIII ) named Leif Pedersen as chief financial officer, effective Oct. 1, succeeding Atul Kavthekar. Pedersen, 48. most recently served as vice president of finance and Shared Service CFO at UnitedHealth Group's ( UNH ) Optum Health division, P3 Health ( PIII ) said Thursday in a regulatory filing....
Copyright 2023-2026 - www.financetom.com All Rights Reserved